The TMPRSS11F antibody targets TMPRSS11F (Transmembrane Serine Protease 11F), a member of the type II transmembrane serine protease (TTSP) family. These proteases are characterized by a conserved serine protease domain, a transmembrane anchor, and distinct regulatory regions. TMPRSS11F, also known as HAT-like 5. is expressed in epithelial tissues and is implicated in proteolytic processing of extracellular substrates, potentially influencing cellular signaling, tissue remodeling, and pathogen entry. Its role in physiological and pathological processes remains under investigation, though related TTSPs are known to regulate viral infectivity (e.g., influenza, coronaviruses) and cancer progression via substrate cleavage.
Antibodies against TMPRSS11F are primarily used as research tools to study its expression, localization, and function. They enable detection in immunoassays (e.g., Western blot, immunohistochemistry) and functional studies to explore its interaction with viral glycoproteins or involvement in disease pathways. Emerging evidence suggests TMPRSS11F may contribute to airway inflammation or tumorigenesis, making it a potential biomarker or therapeutic target. However, its precise biological role and clinical relevance require further validation. Commercial TMPRSS11F antibodies are typically validated for specificity in human or model organisms, aiding mechanistic studies in respiratory diseases, oncology, and infectious disease research.